- Blood Pressure and Hypertension Studies
- Organ Donation and Transplantation
- Renal and Vascular Pathologies
- Organ Transplantation Techniques and Outcomes
- Renal Transplantation Outcomes and Treatments
- Hormonal Regulation and Hypertension
- Hemodynamic Monitoring and Therapy
- Sodium Intake and Health
- Dialysis and Renal Disease Management
- Neurological Complications and Syndromes
- Liver Disease and Transplantation
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiovascular Health and Disease Prevention
- Birth, Development, and Health
- Pregnancy and preeclampsia studies
- Cardiovascular Syncope and Autonomic Disorders
- Nutritional Studies and Diet
- Heart Rate Variability and Autonomic Control
- Electrolyte and hormonal disorders
- Diet and metabolism studies
- Transplantation: Methods and Outcomes
- Pharmacological Effects and Toxicity Studies
- Chronic Kidney Disease and Diabetes
- Central Venous Catheters and Hemodialysis
- Clinical practice guidelines implementation
Mayo Clinic
2015-2025
Mayo Clinic in Arizona
2004-2022
WinnMed
1997-2020
Hypertension Institute
1985-2020
University of Glasgow
2020
Arab American Pharmacist Association
2018
American College of Preventive Medicine
2018
American Society of Nephrology
2016
ING Direct
2005
University of Minnesota Rochester
1998-2005
Hypertension is the most common condition seen in primary care and leads to myocardial infarction, stroke, renal failure, death if not detected early treated appropriately. Patients want be assured that blood pressure (BP) treatment will reduce their disease burden, while clinicians guidance on hypertension management using best scientific evidence. This report takes a rigorous, evidence-based approach recommend thresholds, goals, medications of adults. Evidence was drawn from randomized...
These guidelines have been written to provide a straightforward approach managing hypertension in the community. We intended that this brief curriculum and set of recommendations be useful not only for primary care physicians medical students, but all professionals who work as hands-on practitioners. are aware there is great variability access among communities. Even so-called wealthy countries sizable communities which economic, logistic, geographic issues put constraints on care. And, at...
Background: The 2017 American College of Cardiology/American Heart Association (ACC/AHA) Guideline for the Prevention, Detection, Evaluation and Management High Blood Pressure in Adults provides recommendations definition hypertension, systolic diastolic blood pressure (BP) thresholds initiation antihypertensive medication, BP target goals. Objectives: This study sought to determine prevalence implications above treatment goal among US adults using criteria from ACC/AHA guideline Seventh...
Resistant hypertension (RH) is defined as above-goal elevated blood pressure (BP) in a patient despite the concurrent use of 3 antihypertensive drug classes, commonly including long-acting calcium channel blocker, blocker renin-angiotensin system (angiotensin-converting enzyme inhibitor or angiotensin receptor blocker), and diuretic. The drugs should be administered at maximum maximally tolerated daily doses. RH also includes patients whose BP achieves target values on ≥4 medications....
Weber, Michael A.; Schiffrin, Ernesto L.; White, William B.; Mann, Samuel; Lindholm, Lars H.; Kenerson, John G.; Flack, M.; Carter, Barry Materson, J.; Ram, C. Venkata S.; Cohen, Debbie Cadet, Jean-Claude; Jean-Charles, Roger R.; Taler, Sandra; Kountz, David; Townsend, Raymond; Chalmers, John; Ramirez, Agustin Bakris, George Wang, Jiguang; Schutte, Aletta E.; Bisognano, D.; Touyz, Rhian Sica, Dominic; Harrap, Stephen B. Author Information
The 2017 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Care of Living Donors is intended to assist medical professionals who evaluate living kidney donor candidates provide care before, during after donation. guideline development process followed Grades Recommendation Assessment, Development, (GRADE) approach recommendations are based systematic reviews relevant studies that included critical appraisal quality evidence strength...
Background: Chronic kidney disease is common with older age and characterized on renal biopsy by global glomerulosclerosis, tubular atrophy, interstitial fibrosis, arteriosclerosis. Objective: To see whether the prevalence of these histologic abnormalities in increases healthy adults findings are explained age-related differences function or chronic risk factors. Design: Cross-sectional study. Setting: Mayo Clinic, Rochester, Minnesota, from 1999 to 2009. Patients: 1203 adult living donors....
Although resistant hypertension affects a minority of all hypertensives, this group continues to experience disproportionately high cardiovascular event rates despite newer antihypertensive agents. Hypertension represents an imbalance hemodynamic forces within the circulation, usually characterized by elevated systemic vascular resistance. We studied utility serial parameters in selection and titration medication hypertensive patients using highly reproducible noninvasive measurements...
The development of atherosclerotic cardiovascular complications is a common and serious problem for the long-term survivors organ transplantation. Cyclosporine A plus steroid-based immunosuppression regimens in these patients are associated with hypertension, hyperlipidemia, obesity, diabetes mellitus. Whether new immunosuppressive agent tacrolimus (FK506) confers any advantage terms risk factors has been less well studied. We compared serial changes blood pressure, lipids, body weight,...
Live donation benefits recipients, but the long-term consequences for donors remain uncertain. Renal and Lung Living Donors Evaluation Study surveyed kidney (N = 2455; 61% women; mean age 58, aged 24–94; time from 17 years, range 5–48 years) using Short Form-36 Health Survey (SF-36). The 95% confidence intervals White African-American included or exceeded SF-36 norms. Over 80% of reported average above health their sex (p < 0.0001). Donors' age–sex adjusted physical component summary (PCS)...